A Trusted News Partner For Early Startup Success
A Trusted News Partner For Early Startup Success
A Trusted News Partner For Early Startup Success
Are you working on something interesting, share your story with us!
Hippocratic AI, a developer of generative AI agents for healthcare, closed a Series C funding round, raising $126 million at a $3.5 billion valuation and bringing its total funding to $404 million. The funding was led by growth-stage investor Avenir Growth, with participation from new and existing investors including CapitalG (Google’s growth fund), General Catalyst, Andreessen Horowitz, Kleiner Perkins, Premji Invest, UHS, Cincinnati Children’s, WellSpan Health, John Doerr, Rick Klausner, and others.
Established in 2023, Hippocratic AI deployed generative AI agents to manage non-diagnostic, patient-facing tasks. Its AI agents perform administrative and coordinative roles, such as patient intake, appointment scheduling, medication onboarding, social determinants screening, post-discharge follow-ups, and other forms of patient outreach.
According to the company, it has established partnerships with more than 50 major health systems, payers, and pharmaceutical companies across six countries in just over 15 months since launching commercial operations. In a previous funding round in January 2025, Hippocratic AI raised $141 million in Series B at a $1.64 billion valuation.
According to Hippocratic AI, $126 million Series C proceeds will be used for accelerating global expansion, expanding customer deployments, further investing in its safety architecture, and product innovation to enhance the healthcare ecosystem. According to CEO and co-founder Munjal Shah, the capital infusion will help the company to touch more lives and help more people while staying true to their core values of do no harm and patient first.
The increasing acceptance of generative-AI tools in healthcare is especially for supportive, non-diagnostic functions. Hippocratic AI’s success may encourage other AI firms and investors to double down on vertical AI. The safety-first architectural design may become the de facto template for enterprise AI in sensitive fields.
The $126 million Series C funding round at a $3.5 billion valuation marks a significant history for Hippocratic AI and for healthcare. If the company executes on its product innovation and expansion, it could help shape how healthcare is delivered in the coming years.
A Trusted News Partner For Early Startup Success
Disclaimer:
1. We are not SEBI registered. The investment advice or any information provided by us is for education purposes only. We will not be responsible for any of your profit/loss with any channel suggestions. We recommend you to consult your financial advisor before taking any financial decisions.
2. We always strive for accuracy providing support with our best capabilities, but we acknowledge that sometime some content may have some inaccuracies or contains false informations, and we encourage you to inform us of any errors you find so we can make improvements. For queries, contact our email support at contact@saralgroups.com or tel: +91 11696 55255.
3. SGELITE PRIVATE LIMITED is running a private initiative to support the ‘Vocal for Local‘ movement under Saral Startup News initiative. The inclusion of the Indian map and tricolor elements in website and our company documents is purely for artistic and representational purposes to symbolize national pride. It does not imply any official endorsement, partnership, or patronage by the Government of India.
Copyright © 2025 SGELITE PRIVATE LIMITED. All rights reserved.
